Business in the Burbs

Progenics to start tests on treatment

September

Progenics Pharmaceuticals Inc. of Eastview said it will start tests on an experimental treatment for prostate cancer. The therapy, prostate-specific membrane antigen antibody-drug conjugate, combines a prostate-cancer antibody with a cancer drug. The company said that unlike traditional chemotherapy, the treatment delivers the drug selectively to prostate cancer cells.

This entry was posted on Monday, September 8th, 2008 at 12:37 pm by Allan Drury. You can follow any responses to this entry through the RSS 2.0 feed.
Category: Drug testing

Print | Email

It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the Terms of Service.